February 14, 2020 / 1:49 PM / 2 days ago

BRIEF-Sellas Life Sciences Provides Regulatory Update For Nelipepimut-S (NPS)

Feb 14 (Reuters) - Sellas Life Sciences Group Inc:

* SELLAS LIFE SCIENCES PROVIDES REGULATORY UPDATE FOR NELIPEPIMUT-S (NPS) FOR TRIPLE NEGATIVE BREAST CANCER (TNBC) FOLLOWING FDA FEEDBACK

* SELLAS LIFE SCIENCES GROUP INC - FINALIZED DESIGN AND PLAN FOR A PHASE 3 REGISTRATION-ENABLING STUDY OF NPS IN COMBINATION WITH TRASTUZUMAB Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below